Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Boston, Massachusetts 02118


Purpose:

The purpose of this study is to determine if fresolimumab is safe in treating people with systemic sclerosis (scleroderma) and to investigate the effect of fresolimumab in the skin of these individuals.


Criteria:

Inclusion Criteria: - Meet ACR criteria for diffuse systemic sclerosis - < 24 months since onset of first SSc manifestation other than Raynaud's phenomenon - Modified Rodnan Skin Score ≥ 15 - Male or female adult ( ≥ 18 years of age) - Able and willing to give written informed consent and comply with study protocol Exclusion Criteria: - Moderate or severe pulmonary disease w/ FVC < 80% or DLCO < 70% or ground glass and fibrosis > 20% of lung fields by HRCT - Treatment with investigational drug within 4 weeks of screening - Ongoing use of high dose steroids (> 10mg/day) or unstable steroid dose in past 4 weeks - Treatment with immunosuppressive, cytotoxic, or antifibrotic drug within 4 weeks of screening - Positive for HIV, HBV, and/or HCV - Known active infection (bacterial, viral, fungal, mycobacterial, or other); not including fungal infection of nail beds or any major infection requiring hospitalization or treatment with IV antibiotics within 4 weeks of screening - Patients w/ history of malignancy or premalignant lesion - History of keratoacanthoma or squamous cell carcinoma - Moderate to severe hepatic impairment - SSc renal crisis within 6 months or creatinine > 2.0 - Lack of IV access for medication administration - Moderate or severe cardiac disease with significant arrhythmia, heart failure, or unstable angina - Anemia (Hb < 8.5 gm/dL) - Thrombocytopenia or blood clotting disorder - Patients with organ transplant (including allogeneic bone marrow transplant)


NCT ID:

NCT01284322


Primary Contact:

Principal Investigator
Robert Lafyatis, MD
Boston University


Backup Contact:

N/A


Location Contact:

Boston, Massachusetts 02118
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.